Cannabinoid receptor type 1 agonist, ACEA, improves motor recovery and protects neurons in ischemic stroke in mice

1309 Words3 Pages

Tissue damage following cerebral ischemia results from the interaction of complex pathological processes such as excitotoxicity, peri-infarct depolarizations and inflammation as well as apoptosis. (Dirnagl 1999).
The discovery of the eCB signaling system with its ligands, membrane receptors and regulatory proteins has became potential new therapeutic targets in the fields of obesity, drug abuse, pain, stroke and hypertension. Moreover, neuroprotection is a relatively new area for cannabinoid agonists actions and render higher interest is present in medical research.
ACEA is a cannabinoid agonist that has demonstrated neuroprotective properties in different animal models of CNS injury (Bahremand et al., 2009). Other CB1 agonists, also have presented potential neuroprotective effects (Marchalant et al., 2007; Garcia-Arencibia et al., 2007; Docagne et al., 2007; Zani et al., 2007) and are also useful for the treatment of pain, spasticity, glaucoma among other disorders (Watson et al., 2000).
This study was designed to further ascertain the neuroprotective properties of the CB1 agonist following an ischemic stroke.
Using MCAo model in mice, we showed that the CB1R agonist, ACEA, is protective in those brain regions affected by the ischemic event. We also demonstrated that this protective action of ACEA is not simply transient or acute, but lasts for days. The basis for these effects on neuroprotection could be related with the cannabinoids properties on inflammation, free radical scavenging, inhibition of glutamate release and excitotoxicity (Van der Stelt and Di Marzo, 2005).
Direct occlusion of the distal MCA was performed. This model produces the persistent over-expression of the transcription factor Hypoxia-inducible factor 1 alp...

... middle of paper ...

...S.A. 92 (12): 5510–5514.
Watson S., Benson J., Joy J., 2000. Marijuana and medicine: assessing the science base: a summary of the 1999 Institute of Medicine report. Arch. Gen. Psychiatry 57, 547-552.
Youssef F.F., Hormuzdi S.G., Irving A.J., Frenguelli B.G., 2007. Cannabinoid modulation of neuronal function after oxygen⁄glucose deprivation in area CA1 of the rat hippocampus. Neuropharmacology 52, 1327–1335.
Zani A., Braida D., Capurro V., Sala M., 2007. D-tet- rahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors. Br J Pharmacol. 152, 1301–1311.
Zhang L., Schallert T., Gang Zhang Z., Jiang Q., Arniego P., Li Q., Lu M., Chopp M., 2002. A test for detecting long‐term sensorimotor dysfunction in the mouse after focal cerebral ischemia. Journal of
Neuroscience Methods 117; 207‐214.

More about Cannabinoid receptor type 1 agonist, ACEA, improves motor recovery and protects neurons in ischemic stroke in mice

Open Document